World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s.

It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease.

In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain.

Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website

Research survey assesses impact of holidays on Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Insight into Parkinson’s: “join us as we make history”

We talk to the founder of the ‘Insight into Parkinson’s’ summit

Parkinson’s power foods: one-day menus to nourish your brain and body

One-day menu ideas to enrich the microbiome to reduce symptoms

The future generation of advanced therapies for Parkinson’s

Dr Kieran Breen explores the potential of stem cell & gene therapies

Take part in a global Parkinson’s carers survey

The European Parkinson’s Disease Association (EPDA) is inviting carers from within the Parkinson’s community to take part in a survey aiming to shine a light on the physical, financial and emotional difficulties they face. The research – supported by French healthcare devices company Air Liquide – will be used to inform future campaigns and create valuable tools to help carers and the wider Parkinson’s community. Russell Patten, the secretary general of the EPDA, said: “Carers are such an important part of the Parkinson’s community – they provide the firm foundations that support their loved ones who are physically living with the condition. “However, carers’ needs and quality of life are sadly, all too often, overlooked; this can lead to devastating and lasting effects on the individual and the wider society.” The survey is open until 6 September 2019, and is available in English, French, German Italian, Danish, Dutch, Portuguese, Slovenian…

Scottish university reveals multimillion-pound Parkinson’s research partnership

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s. Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition. The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development. Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together. “This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

Parkinson’s may originate in the gut, says new study

A new study, published in medical journal ‘Neuron’, has found evidence to suggest that Parkinson’s may originate in the gut. As part of the study, researchers at Johns Hopkins University School of Medicine, US, injected abnormally folded alpha-synuclein – a protein closely connected to the development of Parkinson’s – into the gut of over 100 mice. After one month the misfolded protein had spread to areas of the brain, with researchers saying the animals’ symptoms closely mirrored the condition in humans. The results follow on from a study in Sweden in 2017, when a team of researchers at the Karolinska Institutet found similar results. Ted Dawson, professor of neurology at Johns Hopkins University and co-author of the research said: “It supports and really provides the first experimental evidence that Parkinson’s disease can start in the gut and go up the vagus nerve.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Insight into Parkinson’s: “join us as we make history”

Recipes & Nutrition

Parkinson’s power foods: one-day menus to nourish your brain and body

Special reports

The future generation of advanced therapies for Parkinson’s

Take part in a global Parkinson’s carers survey

Scottish university reveals multimillion-pound Parkinson’s research partnership

Parkinson’s may originate in the gut, says new study

{title}

Subscribe

World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Insight into Parkinson’s: “join us as we make history”

Recipes & Nutrition

Parkinson’s power foods: one-day menus to nourish your brain and body

Special reports

The future generation of advanced therapies for Parkinson’s

Take part in a global Parkinson’s carers survey

Scottish university reveals multimillion-pound Parkinson’s research partnership

Parkinson’s may originate in the gut, says new study

{title}

Subscribe

Sign in